All | UK | BE | NL | DE | G123b | |
---|---|---|---|---|---|---|
No. respondents | 96,456 | 46,779 | 4423 | 3643 | 6427 | 35,184 |
No. responses | 463,336 | 217,500 | 39,620 | 24,601 | 50,018 | 131,597 |
Age (%) | ||||||
18–29 | 13.8 | 13.3 | 12.6 | 16.6 | 10.9 | 15.5 |
30–39 | 15.7 | 15.9 | 12.8 | 15.2 | 13.4 | 17.2 |
40–49 | 16.7 | 16.6 | 17.3 | 15.8 | 11.6 | 19.0 |
50–59 | 19.7 | 19.9 | 20.3 | 18.1 | 21.9 | 18.6 |
60–69 | 22.2 | 21.6 | 24.9 | 22.8 | 29.1 | 19.7 |
70 or above | 11.8 | 12.6 | 12.2 | 11.5 | 13.1 | 10.0 |
Gender (%) | ||||||
Female | 52.4 | 55.9 | 50.0 | 50.1 | 47.4 | 49.8 |
Male | 47.6 | 44.1 | 50.0 | 49.9 | 52.6 | 50.2 |
Household characteristics | ||||||
Living with at least one 65b years (%) | 19.3 | 18.8 | 20.9 | 17.8 | 20.5 | 19.6 |
Mean household size | 2.3 | 2.3 | 2.2 | 2.1 | 2.1 | 2.6 |
Risk perceptiona (%) | ||||||
Catching coronavirus | 5.3 | 4.2 | 4.2 | 5.3 | 4.7 | 7.7 |
Serious illness from coronavirus | 16.4 | 14.3 | 19.9 | 25.2 | 19.8 | 16.1 |
Spreading coronavirus to vulnerable persons | 22.0 | 19.4 | 20.2 | 26.3 | 26.8 | 24.2 |
Risk or risk mitigation (%) | ||||||
Used face covering | 64.0 | 58.2 | 61.4 | 34.3 | 75.8 | 75.4 |
Vaccinated | 20.7 | 24.7 | 15.7 | 23.6 | 17.0 | 16.3 |
Self-reported high-risk status | 30.3 | 30.1 | 27.1 | 36.0 | 38.1 | 27.7 |
Presentation of symptoms (%) | ||||||
Fever | 1.6 | 1.7 | 1.4 | 1.4 | 1.0 | 1.6 |
Cough | 4.9 | 5.6 | 4.6 | 3.5 | 1.5 | 5.4 |
Shortness of breath | 3.0 | 3.2 | 2.8 | 3.3 | 4.1 | 2.3 |
Headache or body ache | 14.9 | 15.6 | 12.7 | 10.9 | 14.6 | 15.2 |
Congestion | 8.0 | 8.0 | 7.9 | 7.7 | 7.1 | 8.3 |
Sore throat | 4.4 | 5.1 | 4.1 | 3.7 | 3.3 | 3.9 |
Fatigue or tiredness | 6.1 | 7.3 | 5.1 | 5.6 | 5.2 | 5.0 |
Any symptomsc | 25.6 | 26.7 | 23.3 | 21.4 | 24.0 | 26.0 |